Attune Pharmaceuticals develops novel orally-administered small-molecule therapies for the treatment of genetic disorders.
Business Model:
Revenue: $8M
Employees: 11-50
Address: 250 West 55th Street,
City: New York
State: NY
Zip: 10019
Country: US
Attune Pharmaceuticals develops novel orally-administered small-molecule therapies for the treatment of genetic disorders.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2019 | Series B | 6 | $23M |
Boxer Capital LifeSci Venture Partners RA Capital Management RTW Investments Tang Capital Management Venrock Healthcare Capital Partners Boxer Capital LifeSci Venture Partners RA Capital Management RTW Investments Tang Capital Management Venrock Healthcare Capital Partners |
6/2018 | Series B | $23M |
Venrock Healthcare Partners LifeSci Venture Partners RTW Investments RA Capital |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|